TNF and fleck corneal dystrophy: This review aims to provide updated evidence based on RCTs and highlights data beyond RCTs in the realm of therapeutic options, including strategies to optimize responses to anti-TNF therapy, a combination of anti-TNF with immunomodulators and/or biologics, new biological/small molecules therapy, surgical treatment and mesenchymal stem cell therapy in treating FCD.